These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64 related articles for article (PubMed ID: 3011346)
1. Some aspects of the use of contrast agents in magnetic resonance imaging. Niendorf HP; Semmler W; Laniado M; Felix R Diagn Imaging Clin Med; 1986; 55(1-2):25-36. PubMed ID: 3011346 [TBL] [Abstract][Full Text] [Related]
2. Gadolinium-DTPA: a new contrast agent for magnetic resonance imaging. Niendorf HP; Felix R; Laniado M; Schörner W; Claussen C; Weinmann HJ Radiat Med; 1985; 3(1):7-12. PubMed ID: 4070676 [TBL] [Abstract][Full Text] [Related]
3. Paramagnetic contrast agents in magnetic resonance imaging: research at Vanderbilt University. Runge VM; Clanton JA; Price AC; Herzer WA; Wehr CJ; Lukehart CM; Partain CL; James AE Physiol Chem Phys Med NMR; 1984; 16(2):113-22. PubMed ID: 6438656 [TBL] [Abstract][Full Text] [Related]
5. Characteristics of gadolinium-DTPA complex: a potential NMR contrast agent. Weinmann HJ; Brasch RC; Press WR; Wesbey GE AJR Am J Roentgenol; 1984 Mar; 142(3):619-24. PubMed ID: 6607655 [TBL] [Abstract][Full Text] [Related]
6. [Contrast media in magnetic resonance tomography. A review. 1. Physicochemical and pharmacological bases of MR contrast media using gadolinium-DTPA as an example]. Felix R; Semmler W; Schörner W; Laniado M Rofo; 1985 Jun; 142(6):641-6. PubMed ID: 2988062 [TBL] [Abstract][Full Text] [Related]
7. [Gd-DTPA in the diagnosis of brain metastasis]. Kornienko VN; Pronin IN Vestn Rentgenol Radiol; 1994; (5):5-10. PubMed ID: 7785209 [TBL] [Abstract][Full Text] [Related]
8. [The contrast enhancement of brain and spinal cord tumors using Gd-DTPA in magnetic resonance tomography with an extra-low magnetic-field intensity]. Kornienko VN; Pronin IN; Turkin AM; Fadeeva LM Zh Vopr Neirokhir Im N N Burdenko; 1993; (4):13-7. PubMed ID: 8296501 [TBL] [Abstract][Full Text] [Related]
10. Magnetic resonance imaging of thymic epithelial tumors. Kushihashi T; Fujisawa H; Munechika H Crit Rev Diagn Imaging; 1996 Aug; 37(3):191-259. PubMed ID: 8872410 [TBL] [Abstract][Full Text] [Related]
11. [Choice of image sequence in contrast medium nuclear magnetic tomography: contrast behavior of brain tumors following gadolinium-DTPA use in various spin-echo procedures]. Schörner W; Semmler W; Felix R; Laniado M; Speck U; Niendorf HP Rontgenpraxis; 1984 Sep; 37(9):323-6. PubMed ID: 6505861 [No Abstract] [Full Text] [Related]
12. [Preclinical investigation of Mn(II)-diethylenetriaminepentaacetate (Mangapentetate) as paramagnetic contrast agent for magnetic resonance tomography]. Usov VIu; Belianin ML; Karpova GV; Borodin OIu; Filimonov VD Eksp Klin Farmakol; 2008; 71(4):41-6; discussion 47-8. PubMed ID: 18819440 [TBL] [Abstract][Full Text] [Related]
13. [Contrast media in magnetic resonance tomography. A review. 2. Biological basis, research technic and clinical application of gadolinium-DTPA in the diagnosis of intracranial tumors]. Felix R; Schörner W; Laniado M; Semmler W Rofo; 1985 Jul; 143(1):9-14. PubMed ID: 2992021 [TBL] [Abstract][Full Text] [Related]
14. [Changes in tissue T1 of brain tumor following GD-DTPA administration--differences in T1 time course and tissue-blood ratio by histological types]. Yoshida K; Furuse M; Kaneoke Y; Sasou K; Motegi Y No To Shinkei; 1988 Jun; 40(6):531-7. PubMed ID: 3224029 [TBL] [Abstract][Full Text] [Related]
16. [Magnetic resonance tomography of non-acute multiple sclerosis before and after use of a contrast medium (Gd-DTPA)]. Gowin W; Weihe W; Appel C; Mariss G Rontgenpraxis; 1986 Nov; 39(11):367-77. PubMed ID: 3810314 [No Abstract] [Full Text] [Related]
17. [Nuclear magnetic resonance tomography of the orbits. Initial experiences using the paramagnetic contrast medium gadolinium-DTPA]. Markl A; Riedel KG; Oeckler R; Vogl T; Scheidhauer K Digitale Bilddiagn; 1986 Dec; 6(4):151-5. PubMed ID: 3816049 [TBL] [Abstract][Full Text] [Related]
18. Some physicochemical properties of the gadolinium-DTPA complex, a contrast agent for MRI. Gries H; Miklautz H Physiol Chem Phys Med NMR; 1984; 16(2):105-12. PubMed ID: 6505040 [TBL] [Abstract][Full Text] [Related]
19. Use of gadolinium-DTPA as a myocardial perfusion agent: potential applications and limitations for magnetic resonance imaging. Johnston DL; Liu P; Lauffer RB; Newell JB; Wedeen VJ; Rosen BR; Brady TJ; Okada RD J Nucl Med; 1987 May; 28(5):871-7. PubMed ID: 3572546 [TBL] [Abstract][Full Text] [Related]
20. Quantitative magnetic resonance imaging of rat brain tumors: in vivo NMR relaxometry for the discrimination of normal and pathological tissues. Hoehn-Berlage M; Bockhorst K Technol Health Care; 1994 Dec; 2(4):247-54. PubMed ID: 7842309 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]